Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adalimumab in Primary Combination With UVB-311nm Half-side Phototherapy in Patients With Psoriasis

NCT00638261 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT00638261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00638261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adalimumab in Primary Combination With UVB-311nm Half-side Phototherapy in Patients With Psoriasis
Lead sponsor
Medical University of Graz
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2008
Completion date
August 31, 2011
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis